Subclinical disability in valued life activities among individuals with rheumatoid arthritis.
Subclinical disability in valued life activities among individuals with rheumatoid arthritis.
复制标题
DOI:
10.1002/art.24110
复制
发表时间:
2008-10-15
影响因子:
--
通讯作者:
Yelin, Edward
中科院分区:
文献类型:
--
作者:
Katz, Patricia;Morris, Anne;Yelin, Edward
“Subclinical disability,” the need for modifications in task performance or frequency without reporting difficulty in the task, has been identified as a stage along the disability continuum. We estimate the prevalence of subclinical disability in valued life activities (VLAs) among individuals with rheumatoid arthritis (RA), identify characteristics of individuals with VLA subclinical disability, and estimate the ability of VLA subclinical disability to predict later decrements in functioning. Data were from three years of a longitudinal panel study of individuals with RA, for which annual structured telephone interviews are conducted (n=508 in year 1, 442 in year 3). Respondents rated difficulty in VLAs and then reported whether they used any of four behavioral modifications (limitations, extra time, help, equipment) for each. Subclinical disability was defined for each VLA as no reported difficulty with use of any modification. Multiple regression analyses identified predictors of subclinical disability in year 1, and the role of year 1 subclinical disability in development of overt disability between year 1 and year 3. Almost three quarters exhibited subclinical disability in at least one VLA in year 1. Duration of RA was consistently associated with subclinical disbility. Individuals with subclinical disability at baseline were significantly more likely to experience increases in functional limitations (OR=1.09 [1.01,1.18]) and VLA disability (Total VLA: OR=1.14 [1.06,1.23]) over a prospective two-year period. Subclinical disability may be a valuable marker of individuals in a disability transition phase who are particularly susceptible to intervention to enable them to maintain functioning.
登录
查看更多内容
影响因子:
5.4
作者:
Agree, EM
通讯作者:
Agree, EM
DOI:
10.1002/art.21580
发表时间:
2005-12-15
期刊:
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
影响因子:
--
作者:
Katz, PP
通讯作者:
Katz, PP
影响因子:
5.4
作者:
VERBRUGGE, LM;JETTE, AM
通讯作者:
JETTE, AM
DOI:
10.1016/j.apmr.2007.06.016
发表时间:
2007-09-01
影响因子:
4.3
作者:
Maenty, Minna;Heinonen, Ari;Rantanen, Taina
通讯作者:
Rantanen, Taina
影响因子:
3.7
作者:
Gignac, MAM;Cott, C;Badley, EM
通讯作者:
Badley, EM